A-share afternoon review | The Shanghai Index rose 0.27%, innovative drugs and CRO concepts strengthened, and Science Innovation 50 fell more than 2%

The Zhitong Finance App learned that on September 30, the three major A-share indices collectively opened higher, and the trend diverged after rising in the intraday period. The red market fluctuated. The Shenzhen Index and the GEM Index turned green one after another. The market showed the structural characteristics of “pharmaceuticals leading the way, technology correction, and rapid rotation of topics”. By the midday close, the Shanghai Index had risen 0.27% to 3840.83 points, the Shenzhen Index had fallen 0.06% to 12894.61 points, the GEM index had fallen 0.17% to 3137.11 points; Science and Technology Innovation 50 had fallen 2.09%. 2,623 stocks rose and 2,743 stocks fell in the Shanghai and Shenzhen markets. The Shanghai and Shenzhen markets traded 909.3 billion yuan in half a day, an increase of 33.1 billion yuan compared to the previous trading day. In terms of capital, the main capital in early trading flowed into the pharmaceutical, chemical, optoelectronics and other sectors, with a net outflow from the electronics, semiconductor, and computer sectors. The net outflow from the electronics sector exceeded 7.2 billion yuan.

Overview of the plate

On the upward side, on the upward side, pharmaceuticals such as innovative drugs, CRO, and biological products led the way, while the planting industry and commercial vehicle sectors registered the highest gains; individual stocks rebounded in topics such as robotics and dispersive dyes. In terms of decline, the semiconductor and electronics sectors had the highest declines. The real estate sector was drastically adjusted in early trading, and many stocks within the sector fell to a standstill for a while, then fluctuated and rebounded. Shenzhen Property A staged a “ground floor”, and Zhongtian Services and Lujiazui rose and stopped. Overall, on the last trading day before the holiday, market topics rotated rapidly. The main capital was concentrated in pharmaceuticals, and pressure was placed on technology sectors such as semiconductors, etc., and overall market transactions increased slightly compared to the previous trading day.

Popular sections

1. Innovative drugs and CRO concepts are strengthening collectively

The intraday gains of innovative drugs and CRO concepts expanded. Cansino and Tylomab rose and stopped 20CM, Zhaoyan New Pharmaceutical, Minovar, Kangchen Pharmaceutical, and Osecon rose and stopped, Nanmo Biotech rose more than 18%, nearshore protein rose more than 13%, and Pepsis rose more than 10%.

Comment: According to news, on September 29, Kangfang Biotech's overseas partner Summit announced that AstraZeneca will invest 2 billion US dollars in strategic equity investment in Summit and take the lead in promoting clinical research on the use of Evosi and AstraZeneca CLDN18.2 ADC drugs for various gastrointestinal tumors. In addition, Cansino and Tianjin Jiankai, a wholly-owned subsidiary of Jiankai Technology, signed a cooperative development agreement for the mRNA vaccine for glioblastoma (GBM). Meanwhile, multinational pharmaceutical companies continue to step up AI pharmaceuticals. Swiss pharmaceutical giant Roche revealed during an investor event that it will promote the construction of independent artificial intelligence laboratories to speed up the discovery of new drugs.

2. The automotive sector fluctuates and rises in the intraday market

The automobile sector fluctuated and picked up in the intraday period. JAC hit a rise or stop in the intraday period, rising more than 6% in half a day; Songzhi shares, Songyuan Safety, and Dongfeng Technology rose and stopped; Quanfeng Motor hit a rise or stop in the intraday period; GAC Group and BAIC Blue Valley surged higher.

Comment: According to news, Yu Chengdong, executive director of Huawei, recently said that Hongmeng Zhixing will allocate more resources and energy to further strengthen the “Four Realms” investment in Zunjie, Enjoy, Intelligence, and Shangjie, and revealed that the new Zunjie SUV in cooperation between Huawei and JAC is expected to be launched in early 2027. Xiang Xingchu, chairman of JAC, said that Zunjie's long-term investment in the ultra-luxury market will continue, and the product matrix will be further expanded in the future to cover more market segments such as SUVs and sports luxury.

3. The concept of rice wine has been greatly strengthened

The concept of rice wine grew higher and stronger. Guyue Longshan rose and stopped in seconds, Jinfeng Liquor rose more than 3%, and Huijishan once rose more than 6% in the intraday period and then declined.

Comment: According to news, since the second quarter of this year, many major liquor merchants have accelerated the deployment of rice wine channels. Huijishan has signed contracts with regional wine merchants such as Henan Maowujian and Guangdong Guangxinghu Liquor. Guyue Longshan joined hands with Beijing Sugar and Liquor Group to further cultivate the northern market; Guyue Longshan revealed that in the first half of the year, the foreign port market accounted for more than 40% and 102 new dealers were added, and sales of the blue and white wine series increased 35.2% year-on-year. Furthermore, the “Opinions on Promoting High-Quality Development of Classic Historical Industries” previously issued by six departments including the Ministry of Industry and Information Technology proposed cultivating leading enterprises with a scale of 10 billion yuan, and rice wine has received policy attention as a classic historical industry.

4. Continued activity in the direction of solid-state batteries

Individual stocks in the solid-state battery sector continued to be active. Chuanyi Technology, Zizhu Hi-Tech, and Shanghai Xiba all broke out of the 2-row market. Xinya Manufacturing and Longpan Technology rose and stopped, and many stocks within the sector followed suit.

Comment: According to news, seven departments including the Ministry of Industry and Information Technology, the National Development and Reform Commission, and the Ministry of Transport jointly issued the “Fifteenth Five-Year Plan for the Development of the New Battery Industry” on September 28, proposing that all solid-state batteries will initially be used on a large scale by 2030. The cycle life of long-life lithium batteries will reach 15,000 cycles, and the product defect rate of leading enterprises will reach PPB level.